key: cord-0729176-nmndda98
authors: Al Suwaidi, Hanan; Senok, Abiola; Varghese, Rupa; Deesi, Zulfa; Khansaheb, Hamda; Pokasirakath, Sabeel; Chacko, Bino; Abufara, Ibrahim; Loney, Tom; Alsheikh-Ali, Alawi
title: Saliva for molecular detection of SARS-CoV-2 in school-aged children
date: 2021-02-19
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.02.009
sha: 4f483224268445f9caf01d1ddccef2aefd94ec9a
doc_id: 729176
cord_uid: nmndda98

OBJECTIVES: The high diagnostic accuracy indices for saliva SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR) reported in adults has not been demonstrated in children and adequately powered studies focused on the paediatric population are lacking. This study was carried out to determine the diagnostic accuracy of saliva for SARS-CoV-2 RT-PCR in ambulatory children. METHODS: From 1(st)-23(rd) October 2020, we recruited a population-based sample of children presenting for COVID-19 screening in Dubai, United Arab Emirates. Each child provided paired nasopharyngeal (NP) swab and saliva for SARS-CoV-2 RT-PCR N, E and RdRp genes detection. RESULTS: Paired NP swab and saliva samples were obtained from 476 children with mean (±SD) age of 10.8 years (±3.9) and 58.1% were male (n/N=277/476). Nine participants were sampled twice, hence 485 pairs of NP swab/saliva were tested. Viral detection in at least one specimen type was reported in 17.9% (n/N=87/485), with similar detection in NP swab (16.7%; n/N=81/485) and saliva (15.9%; n/N=77/485). Sensitivity and specificity of saliva RT-PCR was 87.7% (95% CI 78.5%-93.9%) and 98.5% (95% CI 96.8%-99.5%). The positive and negative predictive values were 92.2% (95% CI 84.2%-96.3%) and 97.6% (95% CI 95.7%-98.6%) with Kappa coefficient 0.879 (95% CI 0.821-0.937). Concordance of findings between NP swab and saliva did not differ by age (p=0.67) or gender (p=0.29). Cycle threshold (Ct) values were significantly higher in NP swab/saliva pairs with discordant findings compared to those with both specimens positive. CONCLUSION: In light of these findings, we recommend saliva as a diagnostic specimen for COVID-19 screening in children.

With the re-opening of schools, repeated screening for coronavirus disease 2019 2

outbreaks in educational settings. The collection of nasopharyngeal (NP) swabs for 4 COVID-19 screening is difficult in children due to the invasive nature of the sampling 5 process. The ease of collecting non-invasive drooling saliva makes it an attractive 6 specimen for COVID-19 screening in children, particularly when repeated testing is 7 required. Based on data from various studies, saliva is increasingly recognized as an 8 alternative specimen for detection of severe acute respiratory syndrome coronavirus 9 2 (SARS-CoV-2) using reverse-transcriptase polymerase chain reaction (RT-PCR) 10 [1] [2] [3] . Depending on the studied population, the reported diagnostic accuracy of 11 saliva-based SARS-CoV-2 RT-PCR has been shown to be higher or comparable to 12 NP swab-based testing [1] [2] [3] [4] [5] [6] [7] . Furthermore, recent reports have demonstrated the 13 utility of neat saliva without transport media for SARS-CoV-2 RT-PCR in ambulatory 14 symptomatic and asymptomatic adults at community-based screening centers [2] . 15

Studies confirming the usefulness of saliva as an alternative specimen for COVID- 19 16 screening have largely been in adults with a paucity of data in children. Furthermore, 17 a recent report from a small clinical case series suggested poor diagnostic accuracy 18 for saliva specimens in hospitalized children with COVID- 19 [8] . In the context of this 19 inconsistency in diagnostic accuracy for saliva SAR-CoV-2 RT-PCR in children, 20 further investigation with adequately powered studies using representative samples 21 of children is warranted. Therefore, this study was carried out to determine the 22 diagnostic accuracy of saliva for SARS-CoV-2 RT-PCR in ambulatory children 23

presenting for COVID-19 screening.

Setting & participants: This prospective observational diagnostic study is reported 2 according to the Standards for the Reporting of Diagnostic Accuracy Studies 3 (STARD) guidelines 2015 [9] . From 1st-23rd October 2020, we recruited a 4 population-based convenience sample of school children presenting for COVID- 19 5 screening at Dubai Health Authority (DHA) community-based screening centers in 6

Dubai, United Arab Emirates. Indications for testing included contact with confirmed 7 COVID-19 patients, presence of presumptive symptoms or testing for return to 8 school. All children presenting for COVID-19 screening were eligible for participation. 9

Ethical approval for the study was obtained from the Dubai Health Authority 10

Research and Ethics Committee (DSREC-06/2020_15). 11

Sample collection: Informed consent was obtained from parents/guardians and 12 each child provided paired concurrent NP swab and saliva samples. Using sterile 13 containers without transport medium, self-collected saliva samples (1-3 ml) were 14 obtained at least thirty minutes after abstinence from food or drink as previously 15 described [2] . Participants were asked to close their mouths, allow saliva to pool in 16 the mouth for 1-2 minutes and then gently spit into the provided sterile container. NP 17 swab specimens were obtained by trained healthcare personnel using standardized 18 DHA NP swab collection protocol for COVID-19 screening. The NP swabs were 19 placed in the Greiner Bio-One universal transport system (Greiner Bio-One, 20

Kremsmünster, Austria). Both NP swab and saliva specimens were transported in 21 cool boxes with icepacks to the DHA Virology Laboratory for processing. Hilden, Germany) according to the manufacturer's instructions. No additional buffer 1 was added to saliva for reduction of viscosity before processing for RNA extraction. The internal control (10 µL), which is composed of MS2 phage genome for validation 3 of the RNA extraction and reverse transcription was added before extraction. SARS-4

CoV-2 RT-PCR for the detection of three gene targets (N, E and RdRp genes) was was required to detect a sensitivity of 80% and a specificity of 95% [2, 11] . 23

Descriptive statistics for categorical variables are presented as number 24

(percentages) and for continuous variables as mean ± standard deviation (SD) or median (interquartile range; IQR). Comparison of means was carried out using 1 student's t-tests. Using swab RT-PCR as the reference gold standard, the sensitivity, 2 specificity, positive predictive value (PPV), and negative predictive value (NPV) for 3 saliva RT-PCR were calculated with their associated 95% confidence limits. Kappa 4 coefficient was used to estimate the agreement between NP swab and saliva RT-5 PCR. All analyses were carried out using SPSS statistical software version 24 6 (Chicago, Illinois, USA) and statistical significance was set at p value < 0.05. 7 8

A total of 476 children participated in the study with a mean (±SD, min-max) age of 10 10.8 years (±3.9, 3-18 years) and 58.1% were males ( Table 1 ). All children provided 11 a single set of paired NP swab and saliva samples except for nine participants who 12 were sampled on two occasions (Table 1) and saliva samples did not differ by age (p=0.67) or gender (p=0.29). However, for 10 patients with self-reported symptoms compared to those without symptoms, we 11 found statistically significant differences in the mean Ct values for E gene in NP 12 swab and saliva as well as N gene in saliva (Figure 3) . screening [15, 16] . 25

Although children with COVD-19 are largely asymptomatic, they tend to have viral 1 loads comparable to adults [17] . Additionally, the viral load in children under the age 2 of five years has been shown to be significantly higher compared to older children 3 and adults [17] . Therefore, it would be expected that the diagnostic accuracy of 4 saliva in the paediatric population should be on par or superior when compared to 5 adults. Indeed, the sensitivity of saliva RT-PCR in children shown in this study is 6 higher compared to a similar study in adults conducted by our group [2] . The 7 observation that Ct values were higher in pairs where only one sample was positive 8 (discordant findings) compared to samples where both specimens were positive is 9 noteworthy. As lower Ct values correlate with higher likelihood of cultivable virus and 10 infectiousness [18, 19] , the greater concordance between NP swab and saliva 11 results at lower Ct values is reassuring. In other words, concordance between NP 12 swab and saliva results is more likely when it matters the most (i.e. at lower Ct 13 values when children are likely to be more infectious). utilized in the current study and the report by Han et al. [20] . It is interesting that the 2 upper 95% confidence limit for sensitivity demonstrated by Han et al. [20] , overlaps 3 with the point estimate for sensitivity we report in our larger sample size. Our 4 analysis showed very good sensitivity, specificity as well as negative and positive 5 predictive values for use of saliva for COVID-19 screening which was maintained 6

irrespective of inclusion of presumptive positives. Indeed, these diagnostic accuracy 7

indices and the Kappa coefficient for estimate of agreement between NP swab and 8 saliva RT-PCR were improved with exclusion of presumptive positive results. 9

Although obtaining NP swabs in children may be challenging and could result in poor 10 specimen quality, the substantial agreement between both specimen types as shown 11 by the Kappa coefficient values suggests adequacy of the NP swabs in this study. The healthcare worker is also at higher risk of viral transmission if the child is 2 uncooperative during the sampling process. The adoption of saliva as a diagnostic 3 specimen for COVID-19 screening will be useful in overcoming these challenges. to check for RNA degradation is recommended. A limitation of the study is that this 12 was a convenience sampling of children presenting for screening and further work on 13 a larger population of children which includes those under the age of three years is 14 recommended. 15 16 In conclusion, we demonstrate the utility of saliva as a molecular diagnostic 17 specimen for COVID-19 screening in a large cohort of ambulatory school-aged 18 children. Based on our findings, saliva sampling should be routinely used for 19 paediatric COVID-19 screening to reduce the risk of transmission to healthcare 20 workers, limit the strain on resources, and allay testing anxiety in children. 

Saliva sample as a non-invasive specimen for the diagnosis of 9 coronavirus disease-2019 (COVID-19): a cross-sectional study

Alternative Specimen for Molecular COVID-19 Testing in Community Settings and 13

Saliva or Nasopharyngeal Swab Specimens for Detection of 16 SARS-CoV-2

Saliva 18 is a reliable tool to detect SARS-CoV-2

Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute 21 respiratory syndrome coronavirus 2 (SARS-CoV-2)

Detection of SARS-CoV-2 in

Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis

Saliva is not a 4 useful diagnostic specimen in children with Coronavirus Disease

STARD 2015: an updated list of essential items for reporting diagnostic accuracy 8 studies

The 10 Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 11 infection diagnosis?

Requirements for Minimum Sample Size for Sensitivity 13 and Specificity Analysis

Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the

Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR 17 test

Non-19 invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient 20 cohorts with low prevalence

Diagnosis of COVID-1 19 infection in children: Less nasopharyngeal swabs, more saliva

Spit shines for easier coronavirus testing

Age

Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome

SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus 8 Disease 2019 (COVID-19)

Predicting 10 infectious SARS-CoV-2 from diagnostic samples

Duration of infectiousness and correlation with RT-PCR cycle threshold values in 14 cases of COVID-19

Mildly Symptomatic and Asymptomatic Children with COVID-19

Figure 1: Reporting flowchart of study NP: nasopharyngeal Recruited eligible patients: n=476 Index test (saliva SARS-CoV-2 RT-PCR)

Positive: n=66 Negative: n=5 Provided one set of paired NP swab/saliva sample: n=467 Provided two sets of paired NP swab/saliva sample

Saliva RT-PCR presumptive positive: n=6 :n=1 Positive: n=5 Negative: n=398 Presumptive positive n=5 Positive: n=1 Negative: n=1 Presumptive positive: n=4 Reference test (NP swab SARS-CoV-2 RT-PCR)